Unknown NA INTERVENTIONAL 1-arm NCT02717936

Investigation of Desmoplastic Squamous Cell Carcinoma (DesmoPEK)

Prospektive Therapie-Studie Zur Behandlung Des Desmoplastischen Plattenepithelkarzinoms

Sponsor: University Hospital Tuebingen

Conditions Squamous Cell Carcinoma of the Skin

Interventions Immunohistochemistry using Pancytokeratin Staining

Updated 6 times since 2017 Last updated: Mar 24, 2016 Started: Jan 31, 2016 Primary completion: Jan 31, 2018 Completion: Jan 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02717936, this NA trial focuses on Squamous Cell Carcinoma of the Skin and remains ongoing. Sponsored by University Hospital Tuebingen, it has been updated 6 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Feb 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Feb 2020 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Tuebingen

Data source: University Hospital Tuebingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tübingen, Germany